Immunodominance in Major Histocompatibility Complex Class I–restricted T Lymphocyte Responses

Abstract

Of the many thousands of peptides encoded by a complex foreign antigen that can potentially be presented to CD8+ T cells (TCD8+), only a small fraction induce measurable responses in association with any given major histocompatibility complex class I allele. To design vaccines that elicit optimal TCD8+ responses, a thorough understanding of this phenomenon, known as immunodominance, is imperative. Here we review recent progress in unraveling the molecular and cellular basis for immunodominance. Of foremost importance is peptide binding to class I molecules; only approximately 1/200 of potential determinants bind at greater than the threshold affinity (Kd > 500 nM) associated with immunogenicity. Limitations in the TCD8+ repertoire render approximately half of these peptides nonimmunogenic, and inefficient antigen processing further thins the ranks by approximately four fifths. As a result, only approximately 1/2000 of the peptides in a foreign antigen expressed by an appropriate antigen presenting cell achieve immunodominant status with a given class I allele. A roughly equal fraction of peptides have subdominant status, i.e. they induce weak-to-nondetectable primary TCD8+ responses in the context of their natural antigen. Subdominant determinants may be expressed at or above levels of immunodominant determinants, at least on antigen presenting cells in vitro. The immunogenicity of subdominant determinants is often limited by immunodomination: suppression mediated by TCD8+ specific for immunodominant determinants. Immunodomination is a central feature of TCD8+ responses, as it even occurs among clones responding to the same immunodominant determinant. Little is known about how immunodominant and subdominant determinants are distinguished by the TCD8+ repertoire, or how (and why) immunodomination occurs, but new tools are available to address these questions.

The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma

“…The factors that determine CD8 + T cell immunodominance have largely been investigated in animal models and include antigen abundance, temporal antigen presentation, CD8 + T cell precursor frequency, the priming environment and T cell receptor (TCR)/peptide‐HLA class I binding affinity 55. Here, we demonstrate that HLA class I restrictions influence established EBV latency antigen‐specific CD8 + T cell hierarchies.…”

An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions

“…This is mainly due to the selectivity in the antigen-processing steps preceding the CTL response. For each MHC class I allele, only 1 out of 2000 potential peptides will be immunodominant [1]. A prerequisite for the induction of a CTL response is the generation of peptides from their precursor polypeptides.…”

Optimizing cancer immunotherapy trials: Back to basics

“…The CTL response tends to be focused on a limited number of epitopes, a phenomenon termed 'immunodominance' [17]. Attempts to activate Th therefore must ensure that there is not a parallel induction of competitive CTL and that the CTL response remains focused on vaccine-specific epitopes that are tumour-derived.…”